Medication Management

How does Metformin lower blood sugar and reduce insulin resistance?
Metformin is indicated for type 2 diabetes in conjunction with lifestyle changes, and off-label, for polycystic ovarian syndrome (PCOS). Metformin is one of the most commonly prescribed medications in the world.
Pharmpreneur of the week Sony Poulose: ‘It fills me with immense joy when we are able to help our patients in their times of need.’
Success is not only the profit the business makes, but also the difference you make in peoples’ lives. One of our most successful programs is addiction medicine, where we partnered with addiction specialist doctors to provide comprehensive treatment to people with opioid dependence.

Symptoms of MS: Fatigue

In this ongoing series for pharmacists, Nancy Banoub examines the symptoms of MS, their cause and outlines potential remedial steps that can be taken to help mitigate these symptoms.
Why are Manulife patients still being sent to Bayshore HealthCare and Loblaw-owned pharmacies?

Manulife announced a month ago that patients could receive Specialty Drug Care program medications "at a pharmacy of their choosing," but the new program's rollout has taken longer than many expected.
N.S. sexual health clinic can no longer give free birth control to patients in need

Dr. Lianne Yoshida says that for years the clinic has been using donations to provide contraceptive implant and intrauterine devices.
MedsChecks by pharmacies: Interrupting family doctors while getting paid twice as much

Every fax. A piece of paper. Every message. Each of these costs family doctors time and resources.
Not childʼs play

A practical guide to the management of pediatric pain.
Undetectable = Untransmittable: A conversation between Dr. Theresa Tam and HIV activist Jade Elektra

Dr. Theresa Tam, Canada’s chief public health officer discusses the successes and limitations of a public health campaign with Jade Elektra, HIV Activist, drag performer and community builder.
Maker of much-debated ALS drug says it may stop selling it after study showed it didn’t work

The U.S. FDA approved Amylyx Pharmaceuticals’ Relyvrio in September 2022, following a years-long advocacy campaign by patients with amyotrophic lateral sclerosis, or ALS, a fatal muscle-wasting disease.
Obesity drug Wegovy is approved to cut heart attack and stroke risk in overweight patients

The U.S. Food and Drug Administration approved a label change requested by drugmaker Novo Nordisk that expands the use of semaglutide.

How does Metformin lower blood sugar and reduce insulin resistance?

Pharmpreneur of the week Sony Poulose: ‘It fills me with immense joy when we are able to help our patients in their times of need.’

Symptoms of MS: Fatigue

Why are Manulife patients still being sent to Bayshore HealthCare and Loblaw-owned pharmacies?

N.S. sexual health clinic can no longer give free birth control to patients in need

MedsChecks by pharmacies: Interrupting family doctors while getting paid twice as much

Not childʼs play

Undetectable = Untransmittable: A conversation between Dr. Theresa Tam and HIV activist Jade Elektra

Maker of much-debated ALS drug says it may stop selling it after study showed it didn’t work

Obesity drug Wegovy is approved to cut heart attack and stroke risk in overweight patients